Barclays Portfolio holdings
Barclays is a British universal bank whose roots go back to 1690, when the Quakers John Freame and Thomas Gould started a goldsmith banking business in London. The Barclays name came into the business in 1736, when James Barclay, son-in-law of founder John Freame, became a partner. Barclays launched the UK's first credit card, Barclaycard, in 1966, and in 1967 put the world's first cash machine in a branch in Enfield. In 2008 Barclays bought the North American operations of Lehman Brothers, and in 2009 it sold its Barclays Global Investors unit, home of the iShares ETFs, to BlackRock. It runs five divisions: UK consumer banking, UK corporate banking, private banking and wealth management, an investment bank and a US consumer bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$17.5B |
| 2 |
NVIDIA
NVDA
|
+$2.7B |
| 3 |
Intel
INTC
|
+$1.98B |
| 4 |
Broadcom
AVGO
|
+$1.46B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.11B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$35.8B |
| 2 |
Apple
AAPL
|
+$1.83B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$913M |
| 4 |
Microsoft
MSFT
|
+$856M |
| 5 |
Bank of America
BAC
|
+$792M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 49.47% |
| 2 | Technology | 19.84% |
| 3 | Consumer Discretionary | 7.61% |
| 4 | Financials | 5.61% |
| 5 | Communication Services | 3.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3601
BellRing Brands
BRBR
$1.17B
| $361K | ﹤0.01% |
46,977
-3,621
| -7% | -$40K |
2021 Q4
19 quarters
|
|
3602
CALL
YPF Sociedad Anonima ADS
YPF
$14.5B
| $361K | ﹤0.01% |
+7,200
| New | +$368K |
2026 Q3
0 quarters
|
|
3603
Stoneridge
SRI
$146M
| $360K | ﹤0.01% |
54,150
+3,004
| +6% | +$21.4K |
2013 Q2
53 quarters
|
|
3604
Gencor Industries
GENC
$255M
| $359K | ﹤0.01% |
21,064
+1,935
| +10% | +$32.6K |
2023 Q4
11 quarters
|
|
3605
DELISTED
Clear Channel Outdoor Holdings
CCO
| $358K | ﹤0.01% |
152,327
-26,434
| -15% | -$63.1K |
2015 Q2
45 quarters
|
|
3606
Alto Neuroscience
ANRO
$1.21B
| $356K | ﹤0.01% |
13,943
+625
| +5% | +$18.8K |
2024 Q1
10 quarters
|
|
3607
AerSale
ASLE
$255M
| $356K | ﹤0.01% |
67,931
+8,124
| +14% | +$47.4K |
2022 Q1
18 quarters
|
|
3608
Daktronics
DAKT
$960M
| $356K | ﹤0.01% |
20,469
+14,506
| +243% | +$281K |
2013 Q2
53 quarters
|
|
3609
Enanta Pharmaceuticals
ENTA
$339M
| $355K | ﹤0.01% |
26,949
+8,294
| +44% | +$110K |
2013 Q2
53 quarters
|
|
3610
Arrow Financial
AROW
$715M
| $353K | ﹤0.01% |
9,581
+2,092
| +28% | +$82.2K |
2016 Q1
42 quarters
|
|
3611
Arbor Realty Trust
ABR
$262M
| $352K | ﹤0.01% |
91,182
+57,106
| +168% | +$281K |
2018 Q2
33 quarters
|
|
3612
Sana Biotechnology
SANA
$692M
| $352K | ﹤0.01% |
120,647
+71,290
| +144% | +$248K |
2022 Q1
18 quarters
|
|
3613
ACNB Corp
ACNB
$679M
| $351K | ﹤0.01% |
5,636
+4,162
| +282% | +$264K |
2022 Q2
17 quarters
|
|
3614
Aebi Schmidt Holding AG
AEBI
$850M
| $350K | ﹤0.01% |
33,128
+10,040
| +43% | +$124K |
2025 Q3
4 quarters
|
|
3615
Evolent Health
EVH
$552M
| $350K | ﹤0.01% |
100,253
+28,765
| +40% | +$128K |
2016 Q2
41 quarters
|
|
3616
Employers Holdings
EIG
$831M
| $350K | ﹤0.01% |
7,325
-819
| -10% | -$40.5K |
2016 Q1
42 quarters
|
|
3617
LB Pharmaceuticals
LBRX
$1.45B
| $349K | ﹤0.01% |
9,106
+178
| +2% | +$7.36K |
2025 Q3
4 quarters
|
|
3618
Perspective Therapeutics
CATX
$97.6M
| $349K | ﹤0.01% |
127,023
+104,976
| +476% | +$318K |
2024 Q1
10 quarters
|
|
3619
Delek Logistics
DKL
$3.09B
| $349K | ﹤0.01% |
6,556
+6,146
| +1,499% | +$342K |
2024 Q4
7 quarters
|
|
3620
O-I Glass
OI
$801M
| $348K | ﹤0.01% |
61,598
+28,968
| +89% | +$218K |
2022 Q1
18 quarters
|
|
3621
Silvercrest Asset Management
SAMG
$85.6M
| $348K | ﹤0.01% |
32,949
+133
| +0.4% | +$1.34K |
2019 Q1
30 quarters
|
|
3622
Nkarta
NKTX
$107M
| $346K | ﹤0.01% |
132,218
+10,648
| +9% | +$28.3K |
2022 Q1
18 quarters
|
|
3623
Koppers
KOP
$584M
| $346K | ﹤0.01% |
7,597
+4,835
| +175% | +$230K |
2013 Q2
53 quarters
|
|
3624
Summit Midstream
SMC
$423M
| $346K | ﹤0.01% |
11,453
+2,082
| +22% | +$66.9K |
2024 Q3
8 quarters
|
|
3625
CB Financial Services
CBFV
$204M
| $346K | ﹤0.01% |
9,403
+1,198
| +15% | +$44.6K |
2020 Q2
25 quarters
|
|
Similar funds
Barclays's Q3 2026 Portfolio in Review
As of Q3 2026, Barclays held 5,855 positions worth $500B, down 4% from $521B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays withdrew a net $19B in Q3 2026, closing 474 positions and reducing 1,494 holdings. Its most notable exit was ExxonMobil, an estimated $761M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 55% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares Broad USD High Yield Corporate Bond ETF worth $199M.
- Barclays's largest Q3 2026 buy was iShares Broad USD High Yield Corporate Bond ETF: 5,582,517 shares worth $199M.
- Barclays added most to Tesla in Q3 2026, an estimated $17.5B increase.
- Barclays's biggest Q3 2026 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $35.8B.
- Barclays fully exited ExxonMobil in Q3 2026, selling an estimated $761M.
- Barclays's ten largest holdings make up 40% of its $500B portfolio in Q3 2026.
- Barclays opened 525 new positions and closed 474 in Q3 2026.
- Barclays's portfolio value fell 4% quarter-over-quarter to $500B.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.